KCNA3 and cancer: The potential role of KV1.3 channels as cancer therapy targets has been recently evidenced in in vitro and in vivo experimental models of glioblastoma, melanoma, and pancreatic adenocarcinoma, where mKV1.3 inhibition induces apoptotic cell death in vitro (Leanza et al., 2017; Venturini et al., 2017; Checchetto et al., 2019).